Trials / Completed
CompletedNCT01076959
Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis
Humira 40 mg/0.8 mL for Subcutaneous Injection - Drug Use Investigation (All Patient Investigation) for Rheumatoid Arthritis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,972 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
To clarify the following matters: * Unknown adverse reactions (especially clinically significant adverse reactions) * Incidence and conditions of occurrence of adverse reactions in the clinical setting * Factors that may affect the safety and effectiveness of Humira
Conditions
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2010-02-26
- Last updated
- 2012-08-28
- Results posted
- 2012-08-07
Locations
1,723 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01076959. Inclusion in this directory is not an endorsement.